Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Neural Biomarkers in Adult Subjects With Fragile X Syndrome and Typically Developing Subjects

NCT06957054 is registered in ClinicalTrials.gov with Connecta Therapeutics, S.L. as lead sponsor.

NCT NCT06957054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06957054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Neural Biomarkers in Adult Subjects With Fragile X Syndrome and Typically Developing Subjects
Lead sponsor
Connecta Therapeutics, S.L.
Phase
Observational
Overall status
Completed
Start date
December 16, 2024
Completion date
March 20, 2025
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fragile x syndrome (fxs), neurotypical adults